Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTOP/ITE/MTX vs CHOP in Young Patients with T-Cell Non-Hodgkin Lymphoma
NCT01746992Phase 4Unknown
- Sponsor
- Ruijin Hospital
- Start
- Sep 2012
- Primary completion
- Sep 2018
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of pirarubicin in T-cell non-Hodgkin lymphoma, sponsored by Ruijin Hospital. Status: unknown.
02
Drugs
pirarubicin
03
Conditions
T-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT01746992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01746992.